Fusion Pharmaceuticals is a clinical-stage biopharmaceutical company developing radiopharmaceuticals for the treatment of cancer. Its Targeted Alpha Therapies platform uses a proprietary Fast-Clear linker to connect alpha particle emitting isotopes to antibodies and other targeting molecules.
Fusion's most advanced programme, FPI-2265, is a potential new treatment for patients with metastatic castration-resistant prostate cancer.
Similar Companies
RayzeBio

Convergent Therapeutics

Actinium Pharmaceuticals

Novartis

AdvanCell
advancell.com.au
OncoFusion Therapeutics

Artbio
artbio.com

Aktis Oncology
aktisoncology.com

Alpha-9 Oncology
a9oncology.com

Fuse Biotherapeutics
fusebiotx.com
Illumina Radiopharmaceuticals

Mariana Oncology

Radionetics Oncology
radionetics.com

Firefly Bio

Fuse Oncology
fuseonc.com

Shine Medical Technologies
shinefusion.com

Lumiphore
lumiphore.com

NuView Life Sciences

Theratechnologies
theratech.com

Nucleus RadioPharma
nucleusrad.com

Ratio Therapeutics
ratiotx.com
Quick Facts
Who are Fusion Pharmaceuticals' competitors?
Companies similar to Fusion Pharmaceuticals include Convergent Therapeutics, Actinium Pharmaceuticals, Novartis and AdvanCell.
When was Fusion Pharmaceuticals founded?
Fusion Pharmaceuticals was founded in 2014.
Where is Fusion Pharmaceuticals' headquarters located?
Fusion Pharmaceuticals' headquarters is located in Hamilton, ON, CA.
How much disclosed funding has Fusion Pharmaceuticals raised?
As of Mar 19, 2024, Fusion Pharmaceuticals has disclosed funding of $130M (USD). Undisclosed round amounts are excluded.
Classification
- Industry
- Technology
- Geographic Exposure
- Tags
- Also Known As
- Fusion Pharmaceuticals Inc.
- Fusion Pharma
- Headquarters
- 270 Longwood Road South
- Hamilton, ON, L8P 0A6
- CA
